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Background: Both extensively hydrolysed formulas (eHF) and amino acid-based formula (AAFs) have been
demonstrated effective for the treatment of CMA. However, in clinical practice, parents complain that
hydrolysates are rejected by children due to their bad taste. Flavor of hydrolysed formulas has been poorly
investigated although it affects the acceptance of milk over all the other attributes. The aim of the present
study was to understand the factors underlying the unpleasant flavor of hydrolysed 25 formulas and amino
acid-based formula.
Subjects and methods: One hundred and fifty trained panelists performed a randomized-double-blind test
with different milks. The smell, texture, taste and aftertaste of each formula were evaluated on a scale ranging
from −2 (worst) to 2 (best).
Results: Formulas showed significant difference, as compared to cow’s milk, in smell, texture, taste and
aftertaste. Overall, whey eHFs were judged of better palatability than casein eHF and the AAFs (p < 0.05).
Whey eHF showed significant differences among them for sensory attributes, especially for taste and
aftertaste.
Conclusions: These results suggest that a broad range of flavor exists among the hydrolysed formulas.
Further studies, adequately designed to investigate the relationship between milks’ flavor and nutrient profile
of hydrolysed formulas are warranted.
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Cow’s milk allergy (CMA) affects 2-6% of children with
a prevalence peak during the first year of age [1]. The
prognosis of CMA is good with a recovery of about 50%
at one year and 80% by the fifth year of age [2,3], al-
though recent studies suggest that CMA may now be a
more persistent disease [4-6]. The effective treatment for
CMA is cow’s milk protein exclusion diet.
The formulas intended for treatment (e.g. extensively
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unless otherwise stated.molecular weight <3000 Daltons [7]. Extensively hydro-
lysed formulas (eHF) are comprised of short peptides
mostly < 1500 dalton and free amino acids obtained by
enzymatic hydrolysis followed by further processing such
as heat treatment and/or ultrafiltration.
Although the majority of infants and children with
CMA tolerate an extensively hydrolyzed formula with
whey or casein as a nitrogen source, some infants may
react to eHF as they possess residual allergenicity.
Indeed, It has been recommended that dietary products
for treatment of CMA in infants should be tolerated by at
least 90% (with 95% confidence) of infants with CMA in
clinical studies [8]. Only some extensively hydrolysed
formulas (eHF) and amino acid-based formula (AAF), that
are considered anallergenic, meet these criteria [9].pen Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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extensively hydrolysed (eHF) formula as the first choice
for the treatment of CMA [10-12]. The use of amino
acid-based formula is recommended in infants with
CMA characterized by severe symptoms and in infants
not tolerating eHF [13,14].
Aminoacid based formula should be used as first line-
treatment in the case of anaphylaxis and eosinophilic
esopaghitis [12,15]. Moreover, they may be considered as
first therapeutic option in infants with multiple food al-
lergies or in the presence of severe enteropathy indicated
by hypoproteinemia and failure to thrive [11,16,17].
Both EHF and AAF have been demonstrated effective
for the treatment of CMA. However, in clinical practice,
frequent complaints by parents are that hydrolysates are
rejected by children due to the bad taste [18,19].
Thus an understanding of the factors that underlie
their unpleasant flavor is important and could have the
practical result of improving their palatability thereby
enhancing acceptance.
The unpleasant flavor of hydrolysed has been related
to the peptides produced during proteolysis [20]. Other
authors postulate that the taste depends on the enzymes
used in proteolysis [21].
Pedrosa et al. found a correlation between the amount
of bitter peptides and the palatability of formulas [22].
However, apart from bitterness, we hypothesize that
other sensory attributes may contribute to the palatabil-
ity of hydrolysed formulas.
The aim of the present study was to understand the
factors underlying the unpleasant flavor of hydrolysed
formulas.
Materials and methods
This double-blind multi-centre study was carried out in
healthy young adults to assess the flavor and relative pal-
atability of different cow’s milk protein hydrolysed for-
mulas and amino acid-based formula. One hundred and
fifty subjects (males 71, females 79; mean (SD) age 28.3
(3.9) years (range 25–30) were recruited among the
staff of three Italian University Hospitals (fifty for each
centre: San Paolo Hospital, Milan; Department of
Pediatrics, Second University of Naples and Department
of Pediatrics, University of Verona). Inclusion criteria
were: age < 30 years, being non-smokers, willingness to
participate. Subjects suffering from rhino-sinusal acute
and any acute and chronic diseases were excluded. At
recruitment the subjects received detailed explanations
about the aim of the study and signed a consent form.
The panelists were trained in two 1-h sessions on each
product tasted.
The local Hospital Ethics Committee approved the
study protocol. The assessed milks samples included
whole cow’s milk (reference), a starting formula, apartially hydrolysed formula, five whey protein extensive
hydrolysed formulas, a casein extensive hydrolysed for-
mula and two amino acid-based formulas. The formulas
were selected among those currently available on the
market and were representative of whey or casein based-
hydrolysed formulas and amino acid mixtures.
Energy and macronutrients composition of whole
cow’s milk, starting formula, cow’s milk protein hydro-
lysed formulas and amino-acid based formulas, as provided
by the manufacturers, are shown in Table 1.
Total energy ranged from 62.5 Kcal/100 ml (whey eHF
3) to 72 Kcal/100 ml (whey protein hydrolysed ) and
protein from 1.6 g/100 ml (whey protein EHF 3 and 5)
to 2.1 g/100 ml (whey protein hydrolysate 1). The total
fats’ amount of the tested formulas was comparable with
that of cow’s milk and starting formula both, while pro-
tein and CHO were lower and higher than cow’s milk,
respectively (p < 0.001).
Extensively whey hydrolysates 1,2,3 and casein hydro-
lysed formula contained more than 50% of peptides with
MW lower than 500–600 Dalton (D); in particular, the
casein eHF 1 had 60% of peptides with MW of 500 D
and 95% lower than 1000 D.
The total fats’ content varied from 3.4 g/100 ml (whey
EHF 3, casein eHF and amino acid mixture 1) to 3.6 g/
100 ml (whey protein hydrolyzate 1, amino acid mixture
2). The distribution of satured, monunsatured and poly-
unsatured fatty acids are different among the formulas,
ranging from 1.2 to 2.1 g/100; from 0.8 to 1.55 g/100 ml
and from 0.6 to 0.7 g/100 ml respectively, compared to
2.4, 1.1 and 0.1 gr/100 ml of cow’s milk. Medium-chain
fatty acids (MCT) were absent in partial and whey-
protein hydrolysate 3; in the other formulas MCT con-
tent ranges from 0.09 g/100 ml (casein-hydrolysate) to
1.8 g/100 ml (whey protein hydrolysate 4).
All formulas contain essential long chain polyunsaturated
linoleic acid (range: 0.44 to 0.61 g/100 ml) and α-linolenic
acid (range: 0.046 - 0.088 g/100 ml).
The carbohydrates (CHO) content of hydrolysates var-
ied from 6.5 g/100 ml (whey EHF 3) to 7.7 g/100 ml
(whey eHF 1). In pHF total CHO content was repre-
sented by lactose. Among eHFs, lactose was contained
in eHF 2.3 and 5 only.
Samples of cow’s milk and formulas were bottled in
identical coded pots.
Each subject received 10 ml of cow’s milk or formula
according to a within-subject randomization computer
generated sequence, to eliminate order effect. The sen-
sory tests were carried out on two days during an after-
noon session at ten-minute interval.
All the subjects involved in the study were unaware of
the milks administered until codes were broken after the
completion of the data analysis. The same trained health
worker (one per centre) distributed samples to the
Table 1 Energy and macronutrients composition of cow’s milk, follow on formula, pHF (partial idrolized formula),
whey eHF (whey protein extensive hydrolized formulas), casein eHF (casein extensive hydrolized formula), AABF
(amino acid mixture)*
Milk Energy Kcal/100 ml Proteins g/100 ml Lipids g/100 ml Nucleotides mg/100 ml Carbohydrates, g/100 ml
Cow’s milk 66 3.2 3.9 4.8
S:2.4 LA:4.8
M:1.1
P:0.1
Follow on formula 67 1.2 3.6 2 7.5
Cs/S:30/70 L:0.57 LA:7.5
LN:0.068
pHF 67 1.3 3.4 2 7.8
Cs/S:0/100 S:1.4 LA:7.8
Peptides: M:1.2
<600:18.8 P:0.6
600-3000:63.2 L:0.524
3000-5000:11.8 LN:0.064
>5000:6.1
Whey eHF 1 72 2.1 3.6 6 7.7
Cs/S:0/100 S:1.75 DTM:6.7
Peptides: M:0.99
<240:16.9 P:0.6
360-600:44.6 MCT:1.44
600-1200:30.2 L:0.51
1200-2400:7.1 LN:0.064
2400-4000:1.2
Whey eHF 2 67 1.65 3.43 0 7.33
Cs/S:0/100 S:1.33 DTM:3.5
Peptides: M:1.23 LA:3.83
<240:16.9 P:0.62
360-600:44.6 MCT:1.37
600-1200:30.2 L:0.5
1200-2400:7.1 LN:0.05
2400-4000:1.2
Whey eHF 3 62.5 1.6 3.4 0 6.5
Cs/S:0/100 S:1.24 DTM:3.4
Peptides: M:1.55 LA: <0.12
0-100:5.4 P:0.61
100-500:45.2 L:0.44
500-1000:26.7 LN:0.05
1000-1500:10.8
1500-3000:9.1
3000-4000:2
>4000:0.8
Whey eHF 4 66 1.8 3.5 3.22 6.8
Cs/S:0/100 S:2.1 PO: 5.7
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Table 1 Energy and macronutrients composition of cow’s milk, follow on formula, pHF (partial idrolized formula),
whey eHF (whey protein extensive hydrolized formulas), casein eHF (casein extensive hydrolized formula), AABF
(amino acid mixture)* (Continued)
Peptides: M:0.8
<200:15.1 P:0.6
200-400:28.8 MCT:1.8
500-1500:31.8 L:0.476
1500-2500:14.3 LN:0.088
2500-3500:6.7
3500-4500:2.5
>4500:0.8
Whey eHF 5 66 1.6 3.5 3.22 7.1
CS/S:0/100 S:1.5 LA:2.9
<200:15.1 M:1.4 PO: 3.6
200-400:28.8 P:0.6
500-1500:31.8 MCT:1.08
1500- L:0.456
2500:14.3 LN:0.084
2500-3500:6.7
3500-4500:2.5
>4500:0.8
Casein eHF 1 68 1.9 3.4 0 7.5
Cs/S:100/0 S:1.45
Peptides: M:1.26
<500:60 P:0.67
500-1000:35 MCT:0.09
1000-2000:4 L:0.61
LN:0.046
AABF 1 67 1.8 3.4 0 7.2
S:1.2
M:1.3
P:0.66
MCT:0.136
L:0.579
LN:0.0579
AABF 2 68 1.89 3.6 0 7
S:1.54
M:1.33
P:0.71
MCT:0.1
L:0.58
LN:0.054
* Cs/S:casein/serum protein; PM:%; Satured (S); Monoinsatured (M); Polynsatured (P); Medium chain tryglicerides (MCT); Linoleic acid (L;) Linolenic acid (LN); dextrin
maltose (DTM); polisaccardies (PO); lactose (LA).
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22°C). Water and unsalted crackers were used as palate
cleansers between samples.
Subjects were firstly invited to smell and to take a sip
of the different milks. The following attributes have been
considered: smell, texture, taste and aftertaste. The pan-
elists were asked to evaluate each attribute on a five-
point scale ranging from-2 (worst) to 2 (best) (Table 2).
An overall judgement of palatability was reported by
each panelist on a ten-point visual analogic scale ranging
from 0 (highly negative) to 9 (highly positive) [23].Statistical analysis and methods
Descriptive data are reported as medians with 25th to
75th centile (Table 3). As sensory attributes were not
normally distributed (Kolmogorov-Smirnov test), signifi-
cant difference for each attribute among the different
formulas was assessed by the Friedman test, and signifi-
cance of post-hoc multiple comparisons by the Schaich-
Hamerle and Conover tests [24]. The association of pal-
atability with nutrient features of milks was tested by
Spearman’s correlation coefficient. A significance level of
0.05 was assumed and statistical tests are two-tailed.
The SPSS software, version 19.0 (SPSS Inc., Chicago. IL),
was used for the statistical analysis.Results
The scores for each sensory attribute and the overall
judgement of palatability are reported in Table 3. All
formulas exhibited worst overall palatability judgement
than cow’s milk (p < 0.0001). Figure 1 shows the distribu-
tion of the overall judgement of palatability for cow’s
milk and all the other formulas, categorized into five
classes.
Formulas showed statistically significant difference, as
compared to cow’s milk, in smell (0.01 p < 0.05), taste
(0.0001 < p < 0.05) and aftertaste( p <0.001). Texture wasTable 2 Definitions and scales for sensory properties
used to describe formulas’ attributes
Attribute Definition and scales
Smell unpleasant (−)→ pleasant (+)
Texture rough (−)→ smooth (+)
Taste unpleasant (−)→ pleasant (+)
Aftertaste long (−)→ short (+)
Smell: the characteristic perceived by the olfactory sense.
unpleasant (−)→ pleasant (+).
Texture: degree to which the surface of the samples feels smooth or rough in
the mouth.
Rough (−)→ smooth (+).
taste: the flavor perceived by the mouth.
Low (−)→ High (+).
Aftertaste: length of time after swallowing the sample the flavor persists in
the mouth.
Long (−)→ short (+).different from cow’s milk for hydrolysate 3 (p < 0.05) and
casein-hydrolysate formula (p < 0.05)
PHF showed better overall judgement of palatability
than any eHF or AAFs (p < 0.05).
With regard to each attribute, whey-eHFs were judged
as having better smell than both casein and AABFs
(p < 0.05). Whey eHF3 and casein hydrolysed formula
showed a rougher texture than other formulas (max-
imum p < 0.05). Casein hydrolysed formula and the
amino acid based formula 2 were judged having the
worst taste of all the formulas (maximum p < 0.05).
The aftertaste, meaning the time of persistence of un-
pleasant taste in the mouth, turned instead shorter for
whey eHFs than for casein hydrolysed formula and AAFs
(p < 0.01). Overall, whey eHFs were judged of better
palatability than casein eHF and the AAFs (p < 0.05.
Moreover, whey eHF showed significant differences
among them for sensory attributes, especially for taste,
that resulted better for the whey eHF 5 and for the after-
taste that resulted shorter for the whey eHF 4 and 5 than
all other whey eHFs (p < 0.05).
The overall judgement of palatability decreased with
increasing levels of total poli-unsatured fatty acids
(Spearman’s correlation coefficient. 0.791, p = 0.007) and
maltodextrines (Spearman’s coeff. corr. 0.723; p = 0.028),
while improved with increasing levels of saturated fatty
acids (Spearman’s coeff. corr. 0.640; p = 0.046), alfa-
linoleic acid (Spearman’s coeff. corr. 0.740; p = 0.010)
and lactose (Spearman’s coeff. corr. 0.715; p = 0.039).
Discussion
The choice of the substitute formula for an individual
child with cow’s milk allergy should be based on patients
characteristics (age and symptoms), and formula’s prop-
erties, firstly documented hypoallergenicity and nutri-
tional adequacy [25,26].
However, it is important to also consider formulas ac-
ceptance that interfere with compliance in clinical practice.
In this regard, palatability of hydrolysed formulas has
been poorly investigated. This study focused primarily
on the flavor and the relative palatability of hydrolysed
formula and aminoacid based formulas. Moreover, it
aimed also to investigate the correlation between hydro-
lysed formulas constituents, other than peptides, and
palatability.
Our results showed significant differences of flavor of
the different extensively hydrolysed formulas, with ca-
sein or whey as a nitrogen source and between eHF and
amino acid based formulas. Overall, whey eHFs were
judged of better palatability than casein eHF and the
AAFs (p < 0.05).
It is noteworthy that whey eHF have been judged dif-
ferent among them for sensory attributes and overall
palatability judgement. The sensory attributes that most
Table 3 Flavor of the different formulas
Attribute* Cow’s
milk
Starting
formula
Partial
hydrolisate
Serum
protein
hydr 1
Serum
protein
hydr 2
Serum
protein
hydr 3
Serum
protein hydr 4
Serum
protein
hydr 5
Casein
extensive
hydr
Amino
acid
mixtures
1
Amino
acid
mixtures
2
P
value†
Smell 2 (1 ; 2)** 0 (−1 ;
1)b
1 (0 ; 1)b 0 (−1 ;
1)b
0 (−1 ;
1)b
0 (−1 ;
1)b
0 (−1 ; 1)b 0 (−1 ;
1)b
−2 (−2 ;
−1)c
−1 (−2 ;
−1)c
−2 (−2 ;
−1)c
<0.0001
Texture 1 (0 ; 1)a 1 (0 ; 1)a 1 (0 ; 2)a 1 (0 ; 1)a 1 (0 ;
1)a
0 (−1 ;
1)a
1 (0 ; 2)b 1 (0 ;
1)a
0 (−1 ; 1)c 1 (0 ; 1)a 1 (0 ; 1)a <0.0001
Taste 2 (1 ; 2)a 1 (0 ; 2)b 1 (0 ; 1)b −1 (−2 ;
0)d
−1 (−2 ;
0)d
−1 (−2 ;
0)d
−1 (−2 ; 1)c 0 (−1 ;
1)c
−2 (−2 ;
−1)e
−1 (−2 ;
−1)d
−2 (−2 ;
−1)e
<0.0001
Aftertaste 2 (1 ; 2)a 0 (0 ; 1)b 0 (−1 ; 1)b −1 (−2 ;
−1)c
−1 (−2 ;
0)c
−1 (−2 ;
0)c
0 (−1 ; 1)b 0 (−1 ;
1)b
−2 (−2 ;
−1)d
−2 (−2 ;
−1)d
−2 (−2 ;
−1)d
<0.0001
Total
Judgement
7.5 (6.2 ;
8.4)a
6.0 (5.3 ;
6.9)b
4.6 (3.7 ;
5.8)b
2.4 (1.6 ;
3.2)c
2.8 (2 ;
3.7)d
2.4 (1.3 ;
3.8)c
3.6 (2.8 ; 4.5)e 4 (3.2 ;
4.7)e
1.2 (0.5 ;
2.3)f
1.4 (0.7 ;
2.8)f
1.1 (0.5 ;
1.9)f
<0.0001
*The panelists evaluated each attribute on a scale of −2 to +2; values are medians with 25th to 75th centile quartile point.
**For each specific attribute, different row-superscripts (from a to f) indicate significant difference between formulas.
†Significance of the overall difference among formulas (Friedman's test).
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taste and aftertaste, respectively.
The results also suggest that palatability improved with
the increasing levels of lactose and alfa linolenic content.
Concerning lactose, from a nutritional standpoint, it has
several beneficial effects. Metabolic studies employing
isotopic techniques in humans showed that the presence
of lactose enhances the absorption and the retention of
the calcium [27] and other minerals, such as magnesium
and zinc [28].
Lactose naturally influences the intestinal microflora
as it selectively promotes the development of putative
beneficial bacteria population in the lower part of the
gut [29]. In spite of the above mentioned several and
well-known lactose beneficial effects, lactose continues
to be excluded from the majority of the cow’s milk
based-hydrolysed formulas.
Adverse reactions to lactose in cow’s milk allergy
are not supported in the literature, and complete0
10
20
30
40
50
60
70
80
90
100
Figure 1 Stacked bar chart of the overall judgement of palatability of theavoidance of lactose in CMA is no longer warranted.
EhF containing purified lactose are now available and
have been found safe and effective in the treatment of
CMA [30,31].
With regard to the linolenic acid, our results agree
with data on animals models that demonstrated that
linoleic solutions are preferred over oleic acid and lino-
lenic acid is preferred over linoleic acid [32].
The physiological and nutritional implications of fat
sensing include gastric lipase secretion, modulated the
gastro-intestinal transit, pancreatic exocrine secretions,
gut hormone release, mobilization of stored lipid from
enterocytes, pancreatic endocrine secretion and altered
lipoprotein lipase activity [33]. Through the above activ-
ities, oral fat exposure may influence appetitive re-
sponses, food intake, nutritional status and disease risk.
Therefore, fatty acids content in special formulas
needs further investigation for the all the above men-
tioned aspects.verygood
good
neutral
unpleasant
veryunpleasant
formulas.
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ation between hydrolysed formulas constituents, other
than peptides, and palatability.
The strenght of this study is the large number of pan-
elists (>50) to get statistically valid data [34].
The main limitation of this study is that it was per-
formed in young adults.
Although there are differences in taste preference be-
tween infants and adults [35], a number of studies have
reported that human infants are able to discriminate dif-
ferent taste qualities from birth and they respond to the
stimuli, especially sweet and bitter with a pattern of re-
sponses similar to those seen in adults [36].
The preference of infants and young children for sweet
and aversion for bitter and sour is similar to that of most
occidental adults [37].
The main differences between adults and infants are
the higher preference for sweet-tasting ( meaning that
infants generally prefer higher concentrations of sweet
solutions than adults) and greater aversion for bitter
[38,39], partly due to genetic variations and cultural dif-
ferences [40].
However, it is important to point out that as prefer-
ences for taste stimuli is generally more influenced by
innate factors, preferences for flavor compounds recog-
nized by the sense of smell is more highly influenced by
learning, especially early in life [41].
Experimental studies by Mennella [42] demonstrated
that infants exposed before 4 month of age to hydrolysed
formulas, characterized by a bitter tastes and unpleasant
odor volatiles , were more wiling to accept them than
older infants and the acceptance pattern that infants de-
velop is specific to the flavor profile experienced in the
first months of age [43].
However, considering that feeding with hydrolysed for-
mulas start not infrequently after four months of age, it
is as much as real that the poor palatability of hydro-
lysed formulas continues to be a cause of poor compli-
ance in clinical practice [18].
Another limitation was that the ingredients of the for-
mulas have not been independently manipulated.
Within these limitations, this study highlights that a
broad range of flavor exists among the hydrolysed
formulas, which seems to depend no only on the pep-
tides content and molecular weight but also on other
constituents, e.g. lipids and lactose content.Conclusions
In conclusion, the present study provide some useful in-
formations on flavor of different hydrolysed formulas
and on their relative palatability. However, the design of
the study can not make definitive conclusions about
what factors underlie these differences.Further studies to investigate the correlation among
hydrolysed formula constituents, independently manipu-
lated, and palatability are warranted.
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